William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DLocal, Cognyte, Dutch Bros, and Lumen and Encourages Investors to Contact the Firm
-
SpeedBird and Northern Jet Management to Merge, Becoming One of The Top 20 Private Jet Operators in the United States
-
Viking Therapeutics (VKTX) Prices 17.24M Share Offering at $14.50/sh
-
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
-
Viking Therapeutics (VKTX) Announces Proposed Public Offering of Common Stock
-
Viking Therapeutics Announces Proposed Public Offering of Common Stock
-
LongueVue Capital Successfully Exits TileBar, a Leading Omni-Channel Brand Disrupting The Flooring Sector
-
EQT Value-Add Infrastructure to acquire Lazer Logistics, a leading North American provider of outsourced yard management and spotting services
-
Harvest Partners Reaches Agreement to Sell Lazer Logistics
-
Column-Shadow bank boxing as money funds drain deposits :Mike Dolan
-
SCALE Global Partners with Merchant; Appoints Tim Bello to Advisory Board
-
William Blair Upgrades Parsons Corp. (PSN) to Outperform, 'well-positioned to benefit from PFAS regulations'
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Catalent, Tesla, DLocal, and Cognyte and Encourages Investors to Contact the Firm
-
William Blair sees a multiple risk for Palantir, reiterates Underperform
-
Guardian Capital Partners Exits Portfolio Company, Tactical Medical Solutions, to CNL Strategic Capital
-
William Blair reiterates Underperform Rating on Palantir Technologies Inc. (PLTR), sees a multiple risk
-
Carvana (CVNA) note exchange offer could mitigate near-term cash interest burden - William Blair
-
William Blair Reiterates Underperform Rating on Palantir Technologies Inc. (PLTR)
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tesla, DLocal, Cognyte, and Dutch Bros and Encourages Investors to Contact the Firm
-
William Blair Reiterates Outperform Rating on Dave & Buster's (PLAY); Expects Healthy 25%-Plus EPS Growth in 2023
-
Cellipont Receives Strategic Debt Investment from OrbiMed to Complete State-of-the-Art Commercial Manufacturing Facility
-
ClassWallet Announces Significant Minority Growth Partnership with Guidepost Growth Equity
-
Aehr Receives Volume Production Order for WaferPak Full Wafer Contactors from Major Silicon Carbide Semiconductor Customer for Test and Burn-in of Silicon Carbide Semiconductor Wafers
-
Tyree & D’Angelo Partners Announces Minority Growth Investment in Western Veterinary Partners, led by LGT Capital Partners, Hamilton Lane, and Apogem Capital
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Catalent, Tesla, DLocal, and Cognyte and Encourages Investors to Contact the Firm
-
Amazon (AMZN) increasingly sensitive to AWS performance - William Blair
-
William Blair reiterates Outperform rating on Amazon.com (AMZN), deep-dive shows Prime offers 'exceptional value'
-
CRISPR Therapeutics (CRSP) Announces Transition of Chief Financial Officer
-
CRISPR Therapeutics Announces Transition of Chief Financial Officer
-
Form N-CEN WILLIAM BLAIR FUNDS For: Dec 31
-
Vertellus Acquires CENTAURI Technologies and Rebrands as Aurorium
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cognyte, Dutch Bros, Lumen, and Vertex Energy and Encourages Investors to Contact the Firm
-
Jasper Therapeutics to Present at Upcoming Conferences
-
Clearwater Analytics Holdings, Inc. (CWAN) prices 13 million share secondary offering at $15
-
Clearwater Analytics Announces Pricing of Secondary Offering of Class A Common Stock
-
GE's investors seek solutions to renewable energy, supply chain challenges
-
Form 24F-2NT WILLIAM BLAIR FUNDS For: Dec 31
-
ePlus to Attend the William Blair 7th Annual Tech Innovators Conference
-
D.A. Davidson Names Liam Healy Head of Institutional Equities
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cognyte, Dutch Bros, and Lumen and Encourages Investors to Contact the Firm
-
MDxHealth Announces Exercise of Option
-
MDxHealth Announces Exercise of Option
-
Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results
-
Pathstone Welcomes New Investment from Kelso & Company, Alongside Continued Commitment from Existing Investor, Lovell Minnick Partners
-
EngageSmart Announces Closing of Public Offering of Common Stock by Selling Stockholders
-
Hillman Closes Secondary Offering of Common Stock by Selling Stockholders; Underwriters Fully Exercise Overallotment Option
-
Hillman Closes Secondary Offering of Common Stock by Selling Stockholders; Underwriters Fully Exercise Overallotment Option
-
Ritchie Bros. Thanks Shareholders for Their Strong Support of IAA Acquisition
-
InvestCloud Launches White FMB+
-
Arsenal Capital Partners Sells Airnov Healthcare Packaging to Colorcon

